
pmid: 10888412
Side effects associated with chemotherapy and radiotherapy affect mainly a patient's quality of life. Means or agents designed to alleviate toxicities of anticancer treatments have been marketed or are under active investigation. In this paper, we review the reports published in this field in 1999.
Chemoprevention -- methods, Clinical Trials as Topic, Radiotherapy, Antineoplastic Agents -- adverse effects, Antineoplastic Agents, Radiation-Protective Agents, Sciences bio-médicales et agricoles, Chemoprevention, Adjuvant -- adverse effects, Neoplasms -- drug therapy, Chemotherapy, Adjuvant, Neoplasms, Preventive Medicine -- methods, Chemotherapy, Humans, Radiotherapy, Adjuvant, Preventive Medicine, Radiation-Protective Agents -- therapeutic use
Chemoprevention -- methods, Clinical Trials as Topic, Radiotherapy, Antineoplastic Agents -- adverse effects, Antineoplastic Agents, Radiation-Protective Agents, Sciences bio-médicales et agricoles, Chemoprevention, Adjuvant -- adverse effects, Neoplasms -- drug therapy, Chemotherapy, Adjuvant, Neoplasms, Preventive Medicine -- methods, Chemotherapy, Humans, Radiotherapy, Adjuvant, Preventive Medicine, Radiation-Protective Agents -- therapeutic use
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
